Press Release Aug 07 2025
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has announced that it received a Notice of Compliance from Health Canada for ZDS-Varenicline tablets in two dosages, marking its first approval in Canada. The tablets are intended to assist with smoking cessation and will be manufactured at Zydus's facility in Ahmedabad.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jul 29 2025
- Press Release Jul 24 2025
- Press Release 17-07-2025 NewspaperpublicationAGMnotice17072025
- Press Release Jul 16 2025
- Press Release Jul 15 2025
Later from Zydus Lifesciences
- Press Release Aug 08 2025
- Press Release Aug 11 2025
- Press Release Aug 12 2025
- Press Release Aug 13 2025
- Press Release 20-08-2025 Newspaperadvertisement20082025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences